Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Regeneron Uses Voice-to-Text for Science-First Data Digitization Efforts for Animal Research

    Jul 9, 2024, 05:00 AM by User Not Found
    Bio-IT World | When Regeneron began exploring how to digitize scientific information in lab environments, IT engineers didn’t begin by brainstorming their own ideas. They began by shadowing scientists.
    Full story
  • ChargePoint Technology strengthens its global presence by establishing a localised team in India to support the growing pharma manufacturing market

    Jul 8, 2024, 08:37 AM by
    Full story
  • CPHI South East Asia opens as growth prospects outlined for pharmaceutical development in Vietnam, Thailand and Cambodia

    Jul 8, 2024, 08:37 AM by
    Full story
  • CG Life Forms Strategic Communications Group to Integrate Corporate, Scientific and Medical Communications and Social Media Services

    Jul 3, 2024, 07:13 AM by
    Full story
  • Optibrium Demonstrates Accelerated Lead Optimisation in Complex Agrochemical Development

    Jul 3, 2024, 07:13 AM by
    Optibrium announced the publication of a peer-reviewed study in Journal of Computer-Aided Molecular Design, ‘From UK-2A to florylpicoxamid: Active learning to identify a mimic of a macrocyclic natural product’. The paper demonstrates the successful application of the QuanSA (Quantitative Surface-field Analysis) method, part of Optibrium’s BioPharmics platform for 3D molecular design, to accelerate the lead optimisation of a complex macrocyclic natural product during agrochemical development. By significantly reducing the number of synthetic steps required during optimisation, the study supports the commercial viability of complex macrocyclic compounds.
    Full story
  • Indica Labs Expands Availability of HALO Digital Pathology Solutions in Asia Pacific Region Including CE-IVDR Marked HALO AP® Platform

    Jul 3, 2024, 07:12 AM by
    Indica Labs today announces the expansion of their reseller network in the Asia Pacific (APAC) region.
    Full story
  • AKASA Earns 2024 Great Place To Work Certification™

    Jul 2, 2024, 08:45 AM by
    Full story
  • CellMaker bioreactor systems rely on Watson-Marlow’s 300 series laboratory pumps for ease of use and flexibility

    Jul 2, 2024, 08:45 AM by
    Watson-Marlow’s 323Du/D and 323Du/RL peristaltic pumps are available as an accessory with the CellMaker single-use bioreactor systems
    Full story
  • Biora Therapeutics Announces Positive Clinical Trial Results for BT-600

    Jul 2, 2024, 08:45 AM by
    BT-600 was well tolerated and met all trial objectives, demonstrating the NaviCap platform’s ability to deliver therapeutics directly to the colon
    Full story
  • Building On Biotech Confidence With Strategic R&D

    Jul 1, 2024, 10:05 AM by User Not Found
    Bio-IT World | The biotech sector has weathered some recent headwinds in the funding market but is marked by a general air of confidence as we come to close the first quarter of 2024. This confidence was noted in our recent survey of over 130 decision makers in biotech companies, where we found that despite challenging conditions, 87% of respondents reported at least some confidence and 38% were very confident in the overall success of their product.
    Full story
  • Genuus Asia Launches Cutting-Edge B2B Digital Marketing Solutions

    Jul 1, 2024, 08:55 AM by
    Genuus Asia, a prominent name in digital marketing innovation, proudly announces the launch of its comprehensive B2B digital marketing services.
    Full story
  • DoseMe Enhances Web-based User Experience and Capability to Further Scale its Precision Dosing Platform

    Jul 1, 2024, 08:55 AM by
    DoseMe, a leading provider of model-informed precision dosing (MIPD) software, announced today the general availability of its enhanced web-based platform. These technical improvements streamline the workflow and offer the same user experience as fully integrated DoseMeRx customers. This change offers caregivers improved efficiencies.
    Full story
  • Cytiva’s latest innovation significantly improves filtration of high concentration biologics

    Jun 28, 2024, 07:44 AM by
    Full story
  • CatSci announces strategic acquisition of Reach Separations to offer end-to-end separation science support from discovery to manufacture, with the support of Keensight Capital

    Jun 27, 2024, 08:01 AM by
    Full story
  • Avallano Strengthens Leadership with New Chief Strategy Officer to Drive AI-Powered Clinical Research Innovation

    Jun 27, 2024, 08:01 AM by
    Avallano has ann announced the appointment of Michael A. Ibara, PharmD., as Chief Strategy Officer (CSO).
    Full story
  • WCG and MRCT Center Form Task Force to Tackle Ethical Challenges in AI-Based Clinical Research

    Jun 27, 2024, 08:01 AM by
    WCG and the Multi-Regional Clinical Trials Center of Brigham and Women’s Hospital and Harvard are leading a multi-stakeholder task force to address ethical and regulatory challenges in the IRB review of clinical research protocols that use AI.
    Full story
  • Follow the Money: Foresite Capital Invests in Groundbreaking Tech, Synthesizing Therapeutic Cytokines, More

    Jun 27, 2024, 05:00 AM by User Not Found
    Bio-IT World | Foresite Capital launches new fund for groundbreaking technologies, ranging from novel therapeutics to companies at the intersection of technology and biotechnology; Bright Peak Therapeutics intends to advance platform that allows for the conjugation of its enhanced cytokines as payloads to certain antibodies, creating novel and proprietary “Bright Peak Immunocytokines”; more.
    Full story
  • Laudio Expands Work With Children’s National Hospital to Include Nurse Educators

    Jun 26, 2024, 07:17 AM by
    Full story
  • SPT Labtech and Olink Announce New Automated Solution to Accelerate Research with Olink Next Generation Proteomics Technology

    Jun 26, 2024, 07:17 AM by
    Full story
  • Sapio Sciences Introduces Sapio GMP LIMS Offering Unmatched Flexibility for Unique Manufacturing Processes

    Jun 26, 2024, 07:17 AM by
    Sapio Sciences announces key new capabilities to its highly flexible, no/low-code LIMS to support laboratories that must comply with GMP, 21 CFR 11, and EU Annex 11 standards
    Full story
  • «
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28 (current)
  • 29
  • 30
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy